A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis
Clinical trial NCT06952465 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06952465
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-24
- Primary completion
- 2031-11-30
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.